1. Belch, J. J. et al. 2010. “Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial.” Journal of Vascular Surgery 52 (4): 825–33.
2. Bonaca, M. P. et al. 2020. “Rivaroxaban in peripheral artery disease after revascularization.” New England Journal of Medicine 382 (21): 1994–2004.
3. de Donato, G. et al. 2006. “The ILAILL study: iloprost as adjuvant to surgery for acute ischemia of lower limbs.” Annals of Surgery 244 (2): 185–93.
4. de Donato, G. et al. 2007. “Acute limb ischemia in elderly patients: can iloprost be useful as an adjuvant to surgery? Results from the ILAILL study.” European Journal of Vascular and Endovascular Surgery 34 (2): 194–98.
5. Dorigo, B., Cameli, A. M., Trapani, M., Raspanti, D., Dorigo, W. 1994. “L’ischemia critica degli arti inferiori: reperti ematochimici su sangue refluo e osservazioni istologiche.” Giornale Italiano di Angiologia 14: 105–11.
6. Dorigo, W. et al. 2008. “Lower limb revascularization with a new bioactive prosthetic graft: early and late results.” Annals of Vascular Surgery 22 (1): 79–87.
7. Dorigo, W. et al. 2011. “A multicentre comparison between autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene (ePTFE) graft in the treatment of critical limb ischemia in diabetics.” Journal of Vascular Surgery 54 (5): 1332–38.
8. Dorigo, W. et al. 2012. “Results from an Italian multicentric registry comparing heparin-bonded ePTFE graft and autologous saphenous vein in below-knee femoro-popliteal bypasses.” Journal of Cardiovascular Surgery 53 (2): 187–94.
9. Dorigo, W. et al. 2017. “A comparison between aortobifemoral bypass and aortoiliac kissing stents in patients with complex aortoiliac obstructive disease.” Journal of Vascular Surgery 65 (1): 99–107.
10. Dorigo, W. et al. 2017. “A multicenter predictive score for amputation-free survival for patients operated on with a heparin-bonded ePTFE graft for critical limb ischemia.” World Journal of Surgery 41 (1): 306–13.
11. Dorigo, W. et al. 2022. “Autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene as graft materials for below-the-knee femoro-popliteal bypass in patients with critical limb ischemia: a propensity score-matched analysis.” The Surgeon 20 (2): 85–93.
12. Falso, R. et al. 2025. “Contemporary results of intra-arterial thrombolysis for acute and acute-on-chronic lower limb ischemia.” Annals of Vascular Surgery, in press.
13. Govsyeyev, N. et al. 2023. “Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits.” Journal of Vascular Surgery 77 (4): 1107–18.
14. Grifoni, E. et al. 2018. “On-treatment platelet reactivity is a predictor of adverse events in peripheral artery disease patients undergoing percutaneous angioplasty.” European Journal of Vascular and Endovascular Surgery 56 (4): 545–52.
15. Groot Jebbink, E. et al. 2019. “Meta-analysis of individual patient data after kissing stent treatment for aortoiliac occlusive disease.” Journal of Endovascular Therapy 26 (1): 31–40.
16. Liotta, F. et al. 2018. “Therapeutic efficacy of autologous non-mobilized enriched circulating endothelial progenitors in patients with critical limb ischemia: the SCELTA trial.” Circulation Journal 82 (6): 1688–98.
17. Piffaretti, G. et al. 2018. “Results from a multicenter registry of heparin-bonded expanded polytetrafluoroethylene graft for above-the-knee femoropopliteal bypass.” Journal of Vascular Surgery 67 (5): 1463–70.
18. Piffaretti, G. et al. 2019. “Outcomes from the multicenter Italian registry on primary endovascular treatment of aortoiliac occlusive disease.” Journal of Endovascular Therapy 26 (5): 623–32.
19. Piffaretti, G. et al. 2019. “Prevalence and risk factors for heparin-bonded expanded polytetrafluoroethylene vascular graft infection after infrainguinal femoropopliteal bypasses.” Journal of Vascular Surgery 70 (4): 1299–307.
20. Piffaretti, G. et al. 2022. “Endovascular reconstruction for total aorto-iliac occlusion.” Journal of Endovascular Therapy 29 (4): 565–75.
21. Pratesi, C. et al. 1986. “Le rôle de la thrombolyse loco-régionale dans les thromboses tardives des branches de prothèses.” Journal des Maladies Vasculaires 11 (2): 178–84.
22. Pratesi, C. et al. 1989. “La thrombolyse dans l’ischémie aiguë des membres.” Vasa Supplementum 27: 303–7.
23. Pratesi, C. et al. 2017. “Aortoiliac obstructive disease.” In Vascular Surgery: Why, When, How, edited by P. G. Settembrini. Torino: Minerva Medica.
24. Pulli, R. et al. 2011. “Early and long-term comparison of endovascular treatment of iliac artery occlusions and stenosis.” Journal of Vascular Surgery 53 (1): 92–98.
25. Pulli, R. et al. 2012. “Gender-related outcomes in the endovascular treatment of infrainguinal arterial obstructive disease.” Journal of Vascular Surgery 55 (1): 105–12.
26. Pulli, R. et al. 2015. “Early and midterm results of kissing stent technique in the management of aortoiliac obstructive disease.” Annals of Vascular Surgery 29 (3): 543–50.
27. Ricci, I. et al. 2013. “Alterations of haemorheological parameters in patients with peripheral arterial disease.” Clinical Hemorheology and Microcirculation 55 (2): 271–76.
28. Sofi, F. et al. 2005. “Thrombophilic risk factors for symptomatic peripheral arterial disease.” Journal of Vascular Surgery 41 (2): 255–60.
29. Squizzato, F. et al. 2021. “Covered versus bare metal kissing stents for reconstruction of the aortic bifurcation in the ILIACS registry.” Journal of Vascular Surgery 73 (6): 1980–90.
30. Sticchi, E. et al. 2010. “eNOS and ACE genes influence peripheral arterial disease predisposition in smokers.” Journal of Vascular Surgery 52 (1): 97–102.

Chapter Information

Bibliographic Information